Call us now0755-8668-0658 E-mailinfo@immuclin.com
Language: 简体中文 | 繁体中文 | EN
Login Register
Online Inquiry
Early detection
Article Author：admin Category：Early Detection Reading：527

ACTL technology is a new type of anti-tumor biotherapy that combines oncology, immunology, and molecular biology.

Keyword：
Share：
Cancer Prevention
ConditionsCase StudiesCooperative HospitalEarly DetectionPrevention
Home > Treatment & Prevent > Early Detection
Committed to the research and development of products and technologies for targeted cellular immunotherapy for anti-tumor and other diseases
0755-8668-0658
info@immuclin.com
7th Floor, Building A, Tongfang Information Port, No. 11, Langshan Road, North District, Science and Technology Park, Nanshan District, Shenzhen
ACTL Immunotherapy
Functional Mechanism Advantages Safety Indications Protocols Steps Patents Translational Medicine
Treatment & Prevent
Conditions Case Studies Cooperative Hospital Early Detection Prevention Nursing & Care
About Us
Company Introduction Our Culture Milestones Qualification & Honor Team of Experts Activities Jobs Contact Us
Coyright © 2017 Shenzhen Immuclin Biomed, Inc. All rights reserved. 粤ICP备15002248号